Bacterial and Viral Coinfections in Adult Patients Hospitalized With COVID-19 Throughout the Pandemic: A Multinational Cohort Study in the EuCARE Project - Summary - MDSpire

Bacterial and Viral Coinfections in Adult Patients Hospitalized With COVID-19 Throughout the Pandemic: A Multinational Cohort Study in the EuCARE Project

  • By

  • Pontus Hedberg

  • Karol Serwin

  • Maria Francesca Greco

  • Joana P. V. Pereira

  • Dovile Juozapaite

  • Sara De Benedittis

  • Francesca Bai

  • Nadine Lübke

  • Tobias Wienemann

  • Iuri Fanti

  • Florian König

  • Nico Pfeifer

  • Rolf Kaiser

  • Maurizio Zazzi

  • Alessandro Cozzi-Lepri

  • Daniel Naumovas

  • Giulia Marchetti

  • Milosz Parczewski

  • Björn-Erik Ole Jensen

  • Francesca Incardona

  • Anders Sönnerborg

  • Pontus Nauclér

  • April 3, 2025

  • 0 min

Share

Objective:

To investigate the prevalence of bacterial and viral coinfections in adult COVID-19 patients during the wild type, Alpha, Delta, and Omicron variant periods and their association with in-hospital mortality.

Key Findings:
  • Coinfection rates were 2.6% (wild type), 2.0% (Alpha), 3.2% (Delta), and 7.9% (Omicron).
  • Omicron variant showed a significantly increased risk ratio of coinfection compared to pre-Omicron variants (1.88).
  • Patients with coinfections had a higher occurrence (19%) and adjusted risk (1.69) of in-hospital mortality compared to those without.
Interpretation:

Bacterial and viral coinfections were more prevalent during the Omicron period, and these coinfections were associated with an increased risk of in-hospital mortality.

Limitations:
  • The study may not fully represent all geographical regions due to limited data from certain hospitals, particularly in underrepresented areas.
  • Exclusion criteria may limit the generalizability of findings to all hospitalized COVID-19 patients, particularly those with multiple variants.
Conclusion:

The findings highlight the need for ongoing monitoring of coinfections in COVID-19 patients, particularly during the Omicron variant period, to inform clinical practices and antibiotic stewardship effectively.

Original Source(s)

Related Content